CLOs on the Move

Gift of Hope

www.giftofhope.org

 
Gift of Hope Organ & Tissue Donor Network is a not-for-profit organ procurement organization that coordinates organ and tissue donation and provides public education on donation in Illinois and northwest Indiana. As one of 58 OPOs that make up the nation’s donation system, we work with 180 hospitals and serve 12 million people in our donation service area. Since 1986, we have saved the lives of more than 23,000 organ transplant recipients and improved the lives of hundreds of thousands of tissue transplant recipients through our efforts.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Lovelace Respiratory Research Institute

Lovelace Respiratory Research Institute is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Lovelace Respiratory Research Institute is based in Albuquerque, NM. You can find more information on Lovelace Respiratory Research Institute at www.lrri.org

Reperio

Reperio Health is a company that offers at-home biometric health screenings with instant results and 24/7 live support.

Canadian Dental Service Plans

Canadian Dental Service Plans Inc. is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Sandy Springs Fitness

Sandy Springs Fitness is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.